Off the Wire

Sinobiomed Announces New Chief Executive Officer

September 02, 2010

New, Experienced Management Intends to Move Swiftly on Funding, Acquisitions and Corporate Initiatives
 

Actavis Receives FDA Approval of Atomoxetine HCl Capsules

September 01, 2010

No release date set for Atomoxetine
 

Pfizer to Acquire FoldRx Pharmaceuticals

September 01, 2010

Lead product candidate tafamidis meglumine in EU Registration
 

Biodel Announces Name Change for Lead Product Candidate

September 01, 2010

Currently under review by the U.S. Food and Drug Administration
 

MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence

August 31, 2010

Second FDA-Approved Drug Based on MonoSol Rx's PharmFilm® Technology
 

pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema

August 31, 2010

Reduces the review time goal from 10 months to six months
 

GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine

August 30, 2010

Original PDUFA goal date was August 30, 2010
 

Meda acquires Alaven, a US specialty pharma company

August 30, 2010

Strengthens position in the strategic US market
 

Medicis Announces Approval of Additional Strengths of Solodyn(R)

August 30, 2010

Three New Strengths Provide Greater Solodyn Dosing Precision
 

Novartis receives FDA approval of Tekamlo

August 27, 2010

A single-pill combination of aliskiren and amlodipine to treat high blood pressure